Clinical Study
The Impact of Pulmonary Arterial Pressure on Exercise Capacity in Mild-to-Moderate Cystic Fibrosis: A Case Control Study
Table 3
Exercise parameters in cystic fibrosis patients with postexercise PASP ≤35 mmHg and postexercise PASP >35 mmHg.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data are presented as mean ± 1 standard deviation. NS: not significant, WR peak: maximal work rate, VO2 peak: maximal oxygen uptake, AT: oxygen uptake at anaerobic threshold, VO2/HR: peak oxygen pulse, VE/VCO2@AT: ventilatory equivalent for carbon dioxide at anaerobic threshold, VEmax: minute ventilation at peak exercise, VEmax/MVV: minute ventilation at peak exercise to maximum voluntary ventilation ratio, BR: breathing reserve, RER: respiratory exchange ratio, SpO2 peak: oxygen saturation at peak exercise. |